1. Have you checked out Chiron? I have in the past and they are big in the Hep field, a multi-billion dollar company in the US. For their local MD George Weber to join Select's board is a statement of Select's significance in the Hep field and Chiron's interest in SLT's work.
2. And, the Burnett Institute's assoc director R&D coming on board. Why? They must be serious about SLT commercialising its products and are now going to play a more active role. Also, ensures Select will have a better insight to R&D issues.
3. Frost is gone. I don't know the guy or have any feelings towards him, but boy did he get some bagging on HC.
If I judge by the HC posts, we are now rid of the bad reputation on the Select board and have replaced it with a fantastic team poised to succeed.
Best of luck to all SLT holders.
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Held
